Free Trial
→ Your book is inside (From Profits Run) (Ad)tc pixel Free CI Stock Alerts

Cigna Group (CI) Financials

Cigna Group logo
$288.01 +3.97 (+1.40%)
Closing price 05/8/2026 03:59 PM Eastern
Extended Trading
$284.00 -4.01 (-1.39%)
As of 05/8/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Cigna Group

Annual Income Statements for Cigna Group

This table shows Cigna Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 1,867 2,237 2,637 5,104 8,458 5,370 6,704 5,164 3,434 5,957
Consolidated Net Income / (Loss)		 1,843 2,232 2,646 5,120 8,489 5,420 6,782 5,372 3,778 6,288
Net Income / (Loss) Continuing Operations		 1,843 2,232 2,646 5,120 8,489 5,420 6,782 5,372 3,778 6,288
Total Pre-Tax Income 		2,979 3,606 3,581 6,570 10,868 6,790 8,397 5,513 5,269 7,781
Total Revenue		 39,838 41,722 48,569 153,741 164,554 174,126 181,693 193,688 244,408 274,889
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 39,838 41,722 48,569 153,741 164,554 174,126 181,693 193,688 244,408 274,889
Net Realized & Unrealized Capital Gains on Investments		 - -84 1,399 1,565 5,397 1,606 2,330 -411 -1,740 1,035
Premiums Earned		 - - 36,113 39,714 42,627 41,154 39,916 44,237 45,996 40,261
Other Non-Interest Income		 39,838 41,806 11,057 112,462 116,530 131,366 139,447 149,862 200,152 233,593
Total Non-Interest Expense		 36,859 37,864 44,490 145,489 152,248 166,128 172,068 186,729 237,704 265,700
Property & Liability Insurance Claims		 24,341 25,263 27,528 30,819 32,710 33,565 32,184 36,287 38,648 34,349
Other Operating Expenses		 12,367 12,486 16,727 111,721 117,556 130,565 138,008 148,623 197,353 229,608
Amortization Expense		 151 115 235 2,949 1,982 1,998 1,876 1,819 1,703 1,743
Nonoperating Income / (Expense), net		 - -252 -498 -1,682 -1,438 -1,208 -1,228 -1,446 -1,435 -1,408
Income Tax Expense		 1,136 1,374 935 1,450 2,379 1,370 1,615 141 1,491 1,493
Net Income / (Loss) Attributable to Noncontrolling Interest		 -24 -5.00 9.00 16 31 50 78 208 344 331
Basic Earnings per Share		 $7.31 $8.92 $10.69 $13.58 $23.17 $15.89 $21.66 $17.57 $12.25 $22.33
Weighted Average Basic Shares Outstanding		 - 250.89M 246.70M 375.80M 351.85M 320.95M 297.06M 292.36M 273.68M 263.53M
Diluted Earnings per Share		 $7.19 $8.77 $10.54 $13.44 $22.96 $15.75 $21.41 $17.39 $12.12 $22.18
Weighted Average Diluted Shares Outstanding		 - 250.89M 246.70M 375.80M 351.85M 320.95M 297.06M 292.36M 273.68M 263.53M
Weighted Average Basic & Diluted Shares Outstanding		 - 250.89M 246.70M 375.80M 351.85M 320.95M 297.06M 292.36M 273.68M 263.53M
Cash Dividends to Common per Share		 $0.00 $0.04 $0.04 $0.04 $0.04 $4.00 $4.48 $4.92 $5.60 $6.04

Quarterly Income Statements for Cigna Group

This table shows Cigna Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 1,408 1,029 -277 1,548 739 1,424 1,323 1,532 1,868 1,234 1,654
Consolidated Net Income / (Loss)		 1,449 1,107 -212 1,629 825 1,536 1,409 1,632 1,973 1,274 1,861
Net Income / (Loss) Continuing Operations		 1,449 1,107 -212 1,629 825 1,536 1,409 1,632 1,973 1,274 1,861
Total Pre-Tax Income 		1,840 188 79 1,989 1,192 2,009 1,648 2,021 2,295 1,817 2,270
Total Revenue		 49,013 49,602 57,236 60,475 62,686 65,847 65,541 67,230 69,812 72,304 68,763
Net Interest Income / (Expense)		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Income		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Non-Interest Income		 49,013 49,602 57,236 60,475 62,686 65,847 65,541 67,230 69,812 72,304 68,763
Net Realized & Unrealized Capital Gains on Investments		 286 -1,222 271 273 -923 475 277 288 297 171 471
Premiums Earned		 10,998 11,175 11,603 11,454 11,436 11,503 12,736 9,156 9,081 9,288 9,812
Other Non-Interest Income		 37,729 39,649 45,362 48,748 52,173 53,869 52,528 57,786 60,434 62,845 58,480
Total Non-Interest Expense		 46,808 49,054 56,835 58,111 61,118 63,476 63,531 64,872 67,170 70,125 66,136
Property & Liability Insurance Claims		 8,927 9,280 9,440 9,515 9,527 10,166 10,498 7,749 7,842 8,260 7,924
Other Operating Expenses		 37,427 39,323 45,136 48,176 51,155 52,886 52,611 56,701 58,892 61,404 57,822
Amortization Expense		 454 451 423 420 436 424 422 422 436 463 390
Nonoperating Income / (Expense), net		 -365 -360 -322 -375 -376 -362 -362 -337 -347 -362 -357
Income Tax Expense		 391 -919 291 360 367 473 239 389 322 543 409
Net Income / (Loss) Attributable to Noncontrolling Interest		 41 78 65 81 86 112 86 100 105 40 207
Basic Earnings per Share		 $4.79 $3.54 ($0.97) $5.51 $2.65 $5.06 $4.88 $5.76 $7.02 $4.67 $6.30
Weighted Average Basic Shares Outstanding		 292.62M 292.36M 284.07M 279.55M 278.15M 273.68M 267.14M 266.93M 267.13M 263.53M 264.53M
Diluted Earnings per Share		 $4.74 $3.49 ($0.97) $5.45 $2.63 $5.01 $4.85 $5.71 $6.98 $4.64 $6.26
Weighted Average Diluted Shares Outstanding		 292.62M 292.36M 284.07M 279.55M 278.15M 273.68M 267.14M 266.93M 267.13M 263.53M 264.53M
Weighted Average Basic & Diluted Shares Outstanding		 292.62M 292.36M 284.07M 279.55M 278.15M 273.68M 267.14M 266.93M 267.13M 263.53M 264.53M
Cash Dividends to Common per Share		 $1.23 - $1.40 $1.40 - - $1.51 $1.51 - - $1.56

Annual Cash Flow Statements for Cigna Group

This table details how cash moves in and out of Cigna Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 1,217 -213 907 1,556 4,834 -4,697 428 2,361 594 -1,195
Net Cash From Operating Activities		 4,026 4,086 3,770 9,485 10,350 7,191 8,656 11,813 10,363 9,601
Net Cash From Continuing Operating Activities		 4,026 4,086 3,770 9,485 10,350 7,191 8,656 11,813 10,363 9,601
Net Income / (Loss) Continuing Operations		 1,843 2,232 2,646 5,120 8,489 5,420 6,782 5,372 3,778 6,288
Consolidated Net Income / (Loss)		 1,843 2,232 2,646 5,120 8,489 5,420 6,782 5,372 3,778 6,288
Depreciation Expense		 610 566 695 3,651 2,802 2,923 2,937 3,035 2,775 2,775
Non-Cash Adjustments to Reconcile Net Income		 -169 119 -761 -367 -4,153 1,904 585 3,607 2,713 1,879
Changes in Operating Assets and Liabilities, net		 1,742 1,169 1,190 1,081 3,212 -3,056 -1,648 -201 1,097 -1,341
Net Cash From Investing Activities		 -2,574 -1,703 -26,378 -734 2,976 -3,611 3,098 -5,174 -2,102 -4,407
Net Cash From Continuing Investing Activities		 -2,574 -1,703 -26,378 -734 2,976 -3,611 3,098 -5,174 -2,102 -4,407
Purchase of Property, Leasehold Improvements and Equipment		 -461 -471 - -1,050 -1,094 -1,154 -1,295 -1,573 -1,406 -1,212
Purchase of Investment Securities		 -7,159 -7,332 -31,821 -6,506 -6,918 -8,267 -4,650 -6,417 -3,852 -9,054
Divestitures		 - - 0.00 0.00 5,592 -61 4,835 13 521 2,984
Sale and/or Maturity of Investments		 5,046 6,100 5,755 6,822 5,396 5,871 4,208 2,803 2,635 2,875
Net Cash From Financing Activities		 -225 -2,651 23,515 -7,187 -8,533 -8,212 -11,240 -4,294 -7,647 -6,421
Net Cash From Continuing Financing Activities		 -225 -2,651 23,515 -7,187 -8,533 -8,212 -11,240 -4,294 -7,647 -6,421
Issuance of Debt		 0.00 1,661 24,343 -681 4,863 5,235 0.00 2,689 4,462 6,457
Issuance of Common Equity		 36 131 68 224 376 326 389 187 305 203
Repayment of Debt		 -148 -1,563 -131 -4,494 -9,599 -4,714 -2,559 -2,967 -3,402 -7,124
Repurchase of Common Equity		 -139 -2,725 -342 -1,987 -4,042 -7,742 -7,607 -2,284 -7,034 -3,621
Payment of Dividends		 0.00 0.00 - -15 -15 -1,341 -1,384 -1,450 -1,567 -1,611
Other Financing Activities, Net		 26 -155 -423 -234 -116 24 -79 -469 -411 -725
Effect of Exchange Rate Changes		 -10 55 - - 41 -65 -86 16 -20 32
Cash Interest Paid		 244 240 267 1,645 1,439 1,253 1,229 1,330 1,342 1,350

Quarterly Cash Flow Statements for Cigna Group

This table details how cash moves in and out of Cigna Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -1,090 -209 1,807 -2,687 -273 1,747 -555 -3,990 1,685 1,665 -656
Net Cash From Operating Activities		 2,826 1,467 4,840 265 46 5,212 1,920 -1,886 3,418 6,149 1,131
Net Cash From Continuing Operating Activities		 2,826 1,467 4,840 265 46 5,212 1,920 -1,886 3,418 6,149 1,131
Net Income / (Loss) Continuing Operations		 1,449 1,107 -212 1,629 825 1,536 1,409 1,632 1,973 1,274 1,861
Consolidated Net Income / (Loss)		 1,449 1,107 -212 1,629 825 1,536 1,409 1,632 1,973 1,274 1,861
Depreciation Expense		 766 765 741 738 650 646 674 682 697 722 650
Non-Cash Adjustments to Reconcile Net Income		 738 -738 6,492 48 9,987 -9,177 -39 808 -1,059 2,034 -269
Changes in Operating Assets and Liabilities, net		 -127 333 -2,181 -2,150 -11,416 12,207 -124 -5,008 1,807 2,119 -1,111
Net Cash From Investing Activities		 -1,337 -440 -495 -640 -776 -191 1,197 -797 -4,387 -420 -637
Net Cash From Continuing Investing Activities		 -1,337 -440 -495 -640 -776 -191 1,197 -797 -4,387 -420 -637
Purchase of Property, Leasehold Improvements and Equipment		 - - -300 -370 -399 -337 -327 -285 -278 -322 -267
Purchase of Investment Securities		 -2,385 111 -918 -492 -747 -1,695 -1,554 -1,108 -4,898 -1,494 -1,057
Divestitures		 -14 - 0.00 - - 521 2,346 - - 638 20
Sale and/or Maturity of Investments		 351 928 723 222 370 1,320 732 596 789 758 667
Net Cash From Financing Activities		 -2,572 -1,250 -2,529 -2,309 439 -3,248 -3,681 -1,333 2,659 -4,066 -1,141
Net Cash From Continuing Financing Activities		 -2,572 -1,250 -2,529 -2,309 439 -3,248 -3,681 -1,333 2,659 -4,066 -1,141
Issuance of Debt		 1,301 -1,484 4,462 - 366 -366 0.00 296 6,164 -3.00 0.00
Issuance of Common Equity		 54 74 181 40 62 22 69 72 37 25 57
Repayment of Debt		 -2,887 1,198 -2,574 -893 467 -402 -1,591 -9.00 -2,958 -2,566 -563
Repurchase of Common Equity		 -624 -544 -4,022 -990 - -2,022 -1,508 -1,112 - -1,001 0.00
Payment of Dividends		 -362 -358 -401 -392 -390 -384 -412 -401 -402 -396 -417
Other Financing Activities, Net		 -54 -136 -175 -74 -66 -96 -239 -179 -182 -125 -218
Effect of Exchange Rate Changes		 - - -9.00 -3.00 18 -26 9.00 26 -5.00 2.00 -9.00
Cash Interest Paid		 387 311 336 307 394 305 0.00 301 363 307 0.00

Annual Balance Sheets for Cigna Group

This table presents Cigna Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 61,759 153,226 155,774 155,451 154,889 143,885 152,761 155,881 157,919
Cash and Due from Banks		 2,972 3,855 4,619 10,182 5,081 5,924 7,822 7,550 7,676
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 1,563 4,562 4,417 4,205 3,692 3,774 3,695 3,654 3,651
Separate Account Business Assets		 8,423 7,839 8,465 9,086 8,337 7,278 7,430 7,278 7,511
Goodwill		 6,164 44,505 44,602 44,648 45,811 45,811 44,259 44,370 44,924
Intangible Assets		 345 39,003 36,562 35,179 34,102 32,492 30,863 29,417 28,560
Other Assets		 40,055 50,641 54,151 48,766 57,866 48,606 58,692 63,612 65,597
Total Liabilities & Shareholders' Equity		 61,759 153,226 155,774 155,451 154,889 143,885 152,761 155,881 157,919
Total Liabilities		 47,999 112,154 110,395 105,065 107,705 99,131 106,410 114,638 116,045
Short-Term Debt		 424 24,824 10,604 8,852 24,509 10,768 36,657 12,329 41,584
Accrued Interest Payable		 3,963 7,071 7,347 8,515 7,322 7,978 9,955 9,387 9,048
Other Short-Term Payables		 6,622 0.00 22,187 18,655 11,741 22,479 2,104 36,263 5,710
Long-Term Debt		 5,199 39,523 31,893 29,545 31,125 28,100 28,155 28,937 30,871
Separate Account Business Liabilities		 8,423 7,839 8,465 9,086 8,337 7,278 7,430 7,278 7,511
Other Long-Term Liabilities		 23,368 32,897 29,899 30,412 24,671 22,528 22,109 20,444 21,321
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 13,711 41,035 45,344 50,328 47,130 44,688 46,244 41,243 41,874
Total Preferred & Common Equity		 13,711 41,028 45,338 50,321 47,112 44,675 46,223 41,033 41,713
Total Common Equity		 13,711 41,028 45,338 50,321 47,112 44,675 46,223 41,033 41,713
Common Stock		 3,014 27,755 28,310 28,979 29,578 30,237 30,673 31,292 31,794
Retained Earnings		 15,800 15,088 20,162 28,575 32,593 37,940 41,652 43,519 47,865
Treasury Stock		 -4,021 -104 -2,193 -6,372 -14,175 -21,844 -24,238 -31,437 -35,140
Accumulated Other Comprehensive Income / (Loss)		 -1,082 -1,711 -941 -861 -884 -1,658 -1,864 -2,341 -2,806
Noncontrolling Interest		 0.00 7.00 6.00 7.00 18 13 21 210 161

Quarterly Balance Sheets for Cigna Group

This table presents Cigna Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 150,054 149,645 152,761 153,119 155,446 157,639 155,881 150,658 151,651 157,919 153,266
Cash and Due from Banks		 9,585 8,497 7,822 8,439 6,788 5,888 7,550 8,334 4,329 6,025 7,040
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 3,884 3,924 3,695 3,607 3,551 3,594 3,654 3,681 3,621 3,650 3,704
Separate Account Business Assets		 7,324 7,028 7,430 7,416 7,431 7,651 7,278 7,277 7,373 7,533 7,450
Goodwill		 45,811 45,810 44,259 44,258 44,258 44,374 44,370 44,372 44,375 44,924 45,534
Intangible Assets		 31,713 31,324 30,863 30,491 30,176 29,791 29,417 29,045 28,671 28,975 27,318
Other Assets		 51,737 53,062 58,692 58,908 63,242 66,341 63,612 57,949 63,282 66,789 62,220
Total Liabilities & Shareholders' Equity		 150,054 149,645 152,761 153,119 155,446 157,639 155,881 150,658 151,651 157,919 153,266
Total Liabilities		 104,528 103,879 106,410 111,769 113,919 115,341 114,638 110,244 111,221 115,905 110,824
Short-Term Debt		 31,307 10,719 36,657 39,905 10,992 45,365 12,329 47,713 14,226 12,439 43,626
Accrued Interest Payable		 8,499 9,668 9,955 8,857 9,003 8,920 9,387 8,032 7,078 7,695 8,980
Other Short-Term Payables		 7,539 26,672 2,104 3,215 35,378 2,775 36,263 0.00 35,475 36,319 0.00
Long-Term Debt		 28,115 28,094 28,155 31,053 30,175 30,230 28,937 26,455 26,480 30,947 29,371
Separate Account Business Liabilities		 7,324 7,028 7,430 7,416 7,431 7,651 7,278 7,277 7,373 7,556 7,450
Other Long-Term Liabilities		 21,744 21,698 22,109 21,323 20,940 20,400 20,444 20,767 20,589 20,949 21,397
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 45,464 45,702 46,244 41,350 41,527 42,298 41,243 40,414 40,430 42,014 42,442
Total Preferred & Common Equity		 45,445 45,691 46,223 41,181 41,332 42,095 41,033 40,226 40,214 41,805 42,210
Total Common Equity		 45,445 45,691 46,223 41,181 41,332 42,095 41,033 40,226 40,214 41,805 42,210
Common Stock		 30,440 30,567 30,673 30,296 31,052 31,190 31,292 31,447 31,592 31,702 31,918
Retained Earnings		 39,936 40,982 41,652 40,978 42,132 42,480 43,519 44,434 45,564 47,028 49,106
Treasury Stock		 -23,053 -23,739 -24,238 -27,769 -29,410 -29,412 -31,437 -33,065 -34,126 -34,126 -35,216
Accumulated Other Comprehensive Income / (Loss)		 -1,878 -2,119 -1,864 -2,324 -2,442 -2,163 -2,341 -2,590 -2,816 -2,799 -3,598
Noncontrolling Interest		 19 11 21 169 195 203 210 188 216 209 232

Annual Metrics And Ratios for Cigna Group

This table displays calculated financial ratios and metrics derived from Cigna Group's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - -
Valuation Ratios		 - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - -
Efficiency Ratios		 - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - -
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $10.69 $13.58 $23.17 $15.87 $21.54 $17.57 $12.25 $22.33
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 380.06M 372.04M 351.85M 320.95M 297.06M 292.36M 273.68M 263.53M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $10.54 $13.44 $22.96 $15.73 $21.30 $17.39 $12.12 $22.18
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 380.06M 372.04M 351.85M 320.95M 297.06M 292.36M 273.68M 263.53M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $13.58 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 380.06M 372.04M 351.85M 320.95M 297.06M 292.36M 273.68M 263.53M
Debt Service Ratios		 - - - - - - - - - -
Payout Ratios		 - - - - - - - - - -

Quarterly Metrics And Ratios for Cigna Group

This table displays calculated financial ratios and metrics derived from Cigna Group's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 263,528,277.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 263,528,277.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 7.06
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 4.43% 9.34% 19.24% 24.40% 27.90% 32.75% 14.51% 11.17% 11.37% - 4.92%
EBITDA Growth		 -34.28% -51.66% -57.83% 3.33% -25.35% 129.78% 135.03% -2.00% 50.54% - 22.09%
EBIT Growth		 -41.90% -72.34% -79.53% 5.21% -28.89% 332.66% 401.25% -0.25% 68.49% - 30.70%
NOPAT Growth		 -42.50% 164.06% -167.34% 7.51% -37.50% -43.82% 259.70% -1.65% 109.29% - 25.32%
Net Income Growth		 -47.84% -9.41% -116.23% 7.88% -43.06% 38.75% 764.62% 0.18% 139.15% - 32.08%
EPS Growth		 -47.16% -8.64% -122.88% 10.77% -44.51% 43.55% 600.00% 4.77% 165.40% - 29.07%
Operating Cash Flow Growth		 -13.92% -30.11% -3.74% -89.37% -98.37% 255.28% -60.33% -811.70% 7,330.43% - -41.09%
Free Cash Flow Firm Growth		 -96.58% -219.08% 22.37% 245.22% -4,464.45% 225.30% 95.07% -85.69% 207.87% - 333.43%
Invested Capital Growth		 1.19% 32.94% 9.99% -21.20% 39.39% -25.78% 2.02% -1.88% -27.56% - 0.75%
Revenue Q/Q Growth		 0.82% 1.20% 11.82% 9.16% 3.66% 5.04% -0.46% 2.57% 3.84% - -4.90%
EBITDA Q/Q Growth		 -1.03% -55.81% -31.66% 171.63% -28.50% 36.02% -11.04% 13.26% 9.84% - 12.96%
EBIT Q/Q Growth		 -1.87% -75.15% -55.74% 489.53% -33.67% 51.21% -15.23% 17.31% 12.04% - 20.56%
NOPAT Q/Q Growth		 -3.58% 85.83% -197.21% 279.92% -43.95% 67.04% -5.20% 10.80% 19.28% - 40.96%
Net Income Q/Q Growth		 -4.04% -23.60% -119.15% 868.40% -49.36% 86.18% -8.27% 15.83% 20.89% - 46.08%
EPS Q/Q Growth		 -3.66% -26.37% -127.79% 661.86% -51.74% 90.49% -3.19% 17.73% 22.24% - 34.91%
Operating Cash Flow Q/Q Growth		 13.40% -48.09% 229.93% -94.52% -82.64% 11,230.43% -63.16% -198.23% 281.23% - -81.61%
Free Cash Flow Firm Q/Q Growth		 104.43% -3,392.66% 57.34% 314.51% -233.23% 194.53% -101.82% 723.25% 904.13% - 104.28%
Invested Capital Q/Q Growth		 -19.41% 31.43% 1.03% -26.37% 42.57% -30.01% 38.87% -29.19% 5.26% - 0.97%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 6.06% 2.65% 2.06% 5.13% 3.54% 4.58% 4.10% 4.52% 4.78% - 4.77%
EBIT Margin		 4.50% 1.10% 0.72% 3.91% 2.50% 3.60% 3.07% 3.51% 3.78% - 3.82%
Profit (Net Income) Margin		 2.96% 2.23% -0.38% 2.69% 1.32% 2.33% 2.15% 2.43% 2.83% - 2.71%
Tax Burden Percent		 78.75% 588.83% -268.35% 81.90% 69.21% 76.46% 85.50% 80.75% 85.97% - 81.98%
Interest Burden Percent		 83.45% 34.31% 19.70% 84.14% 76.02% 84.73% 81.99% 85.71% 86.87% - 86.41%
Effective Tax Rate		 21.25% -488.83% 368.35% 18.10% 30.79% 23.54% 14.50% 19.25% 14.03% - 18.02%
Return on Invested Capital (ROIC)		 7.98% 12.94% -3.67% 7.32% 3.90% 6.95% 5.84% 8.97% 8.53% - 7.57%
ROIC Less NNEP Spread (ROIC-NNEP)		 7.24% 8.85% -2.33% 6.71% 3.45% 6.43% 5.41% 8.31% 8.03% - 7.18%
Return on Net Nonoperating Assets (RNNOA)		 6.15% 10.07% -3.48% 7.75% 4.48% 7.78% 9.61% 8.30% 11.33% - 12.75%
Return on Equity (ROE)		 14.14% 23.01% -7.15% 15.07% 8.38% 14.73% 15.45% 17.27% 19.87% - 20.32%
Cash Return on Invested Capital (CROIC)		 5.34% -21.32% -4.65% 29.42% -28.22% 34.55% 3.78% 9.88% 39.55% - 6.09%
Operating Return on Assets (OROA)		 5.80% 1.44% 0.97% 5.49% 3.71% 5.70% 5.10% 5.93% 6.39% - 6.99%
Return on Assets (ROA)		 3.81% 2.91% -0.52% 3.78% 1.95% 3.69% 3.58% 4.10% 4.78% - 4.95%
Return on Common Equity (ROCE)		 14.11% 22.95% -7.13% 15.02% 8.35% 14.67% 15.38% 17.18% 19.77% - 20.22%
Return on Equity Simple (ROE_SIMPLE)		 12.01% 0.00% 9.36% 9.61% 7.96% 0.00% 13.42% 13.43% 15.67% - 15.97%
Net Operating Profit after Tax (NOPAT)		 1,736 3,227 -1,076 1,936 1,085 1,813 1,719 1,904 2,271 - 2,154
NOPAT Margin		 3.54% 6.51% -1.94% 3.20% 1.73% 2.75% 2.62% 2.83% 3.25% - 3.13%
Net Nonoperating Expense Percent (NNEP)		 0.74% 4.09% -1.35% 0.61% 0.45% 0.52% 0.43% 0.66% 0.50% - 0.40%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 95.50% 98.90% 99.28% 96.09% 97.50% 96.40% 96.93% 96.49% 96.22% - 96.18%
Earnings before Interest and Taxes (EBIT)		 2,205 548 401 2,364 1,568 2,371 2,010 2,358 2,642 - 2,627
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,971 1,313 1,142 3,102 2,218 3,017 2,684 3,040 3,339 - 3,277
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.82 1.87 2.58 2.27 2.30 1.87 2.24 2.20 1.84 - 1.67
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Price to Revenue (P/Rev)		 0.44 0.45 0.52 0.44 0.42 0.31 0.36 0.34 0.29 - 0.25
Price to Earnings (P/E)		 15.63 16.69 29.33 25.33 31.87 22.37 17.89 17.60 12.52 - 11.18
Dividend Yield		 1.71% 1.67% 1.40% 1.59% 1.57% 2.03% 1.74% 1.76% 2.06% - 2.28%
Earnings Yield		 6.40% 5.99% 3.41% 3.95% 3.14% 4.47% 5.59% 5.68% 7.99% - 8.95%
Enterprise Value to Invested Capital (EV/IC)		 1.34 1.29 1.50 1.55 1.41 1.34 1.36 1.54 1.34 - 1.18
Enterprise Value to Revenue (EV/Rev)		 0.60 0.74 0.83 0.60 0.73 0.45 0.62 0.48 0.43 - 0.49
Enterprise Value to EBITDA (EV/EBITDA)		 9.97 14.34 20.04 15.07 21.45 11.68 14.16 11.40 9.48 - 10.87
Enterprise Value to EBIT (EV/EBIT)		 13.54 20.60 31.27 23.28 34.16 16.52 18.77 15.04 12.21 - 13.92
Enterprise Value to NOPAT (EV/NOPAT)		 20.71 21.14 32.38 24.00 35.17 23.04 23.78 19.12 14.86 - 17.35
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.13 12.13 14.53 13.67 25.20 10.69 20.97 23.60 13.22 - 15.49
Enterprise Value to Free Cash Flow (EV/FCFF)		 25.32 0.00 0.00 4.65 0.00 3.31 36.38 15.44 2.85 - 19.47
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.85 1.40 1.72 0.99 1.79 1.00 1.84 1.01 1.03 - 1.72
Long-Term Debt to Equity		 0.61 0.61 0.75 0.73 0.71 0.70 0.65 0.66 0.74 - 0.69
Financial Leverage		 0.85 1.14 1.49 1.16 1.30 1.21 1.77 1.00 1.41 - 1.78
Leverage Ratio		 3.23 3.26 3.50 3.51 3.49 3.52 3.72 3.75 3.74 - 3.67
Compound Leverage Factor		 2.70 1.12 0.69 2.95 2.65 2.99 3.05 3.21 3.25 - 3.17
Debt to Total Capital		 45.89% 58.30% 63.18% 49.78% 64.12% 50.01% 64.73% 50.17% 50.80% - 63.23%
Short-Term Debt to Total Capital		 12.67% 32.98% 35.53% 13.29% 38.48% 14.94% 41.64% 17.53% 14.57% - 37.79%
Long-Term Debt to Total Capital		 33.22% 25.33% 27.65% 36.49% 25.64% 35.07% 23.09% 32.64% 36.24% - 25.44%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.09% 0.12% 0.15% 0.24% 0.17% 0.25% 0.16% 0.27% 0.24% - 0.20%
Common Equity to Total Capital		 54.02% 41.58% 36.67% 49.98% 35.71% 49.73% 35.11% 49.56% 48.95% - 36.56%
Debt to EBITDA		 3.41 6.49 8.42 4.83 9.72 4.35 6.73 3.71 3.59 - 5.81
Net Debt to EBITDA		 2.66 5.70 7.42 4.03 8.97 3.56 5.97 3.32 3.09 - 5.25
Long-Term Debt to EBITDA		 2.47 2.82 3.68 3.54 3.89 3.05 2.40 2.42 2.56 - 2.34
Debt to NOPAT		 7.07 9.56 13.61 7.69 15.95 8.58 11.30 6.23 5.63 - 9.28
Net Debt to NOPAT		 5.53 8.40 11.99 6.42 14.70 7.01 10.03 5.57 4.85 - 8.39
Long-Term Debt to NOPAT		 5.12 4.15 5.95 5.64 6.38 6.02 4.03 4.05 4.02 - 3.73
Noncontrolling Interest Sharing Ratio		 0.18% 0.23% 0.31% 0.32% 0.32% 0.39% 0.44% 0.50% 0.49% - 0.51%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 738 -24,314 -11,277 24,190 -32,229 30,467 -555 3,462 34,764 - 1,297
Operating Cash Flow to CapEx		 0.00% 0.00% 1,613.33% 71.62% 11.53% 1,546.59% 587.16% -661.75% 1,229.50% - 423.60%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.29 1.31 1.35 1.40 1.49 1.58 1.66 1.69 1.69 - 1.83
Fixed Asset Turnover		 49.41 51.86 54.44 57.70 60.70 66.51 69.35 72.36 73.60 - 75.32
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 84,579 111,163 112,308 82,694 117,893 82,509 114,582 81,136 85,400 - 115,439
Invested Capital Turnover		 2.25 1.99 1.89 2.29 2.25 2.52 2.23 3.17 2.62 - 2.42
Increase / (Decrease) in Invested Capital		 998 27,541 10,201 -22,254 33,314 -28,654 2,274 -1,558 -32,493 - 857
Enterprise Value (EV)		 113,651 143,326 168,868 128,480 166,757 110,735 156,062 124,905 114,512 - 136,485
Market Capitalization		 83,260 86,208 106,180 93,906 96,847 76,809 90,040 88,312 76,942 - 70,296
Book Value per Share		 $154.37 $157.96 $140.86 $145.50 $150.58 $147.52 $146.98 $150.53 $156.62 - $160.17
Tangible Book Value per Share		 ($106.23) ($98.76) ($114.82) ($116.53) ($114.72) ($117.76) ($121.28) ($122.90) ($120.23) - ($116.28)
Total Capital		 84,579 111,163 112,308 82,694 117,893 82,509 114,582 81,136 85,400 - 115,439
Total Debt		 38,813 64,812 70,958 41,167 75,595 41,266 74,168 40,706 43,386 - 72,997
Total Long-Term Debt		 28,094 28,155 31,053 30,175 30,230 28,937 26,455 26,480 30,947 - 29,371
Net Debt		 30,316 56,990 62,519 34,379 69,707 33,716 65,834 36,377 37,361 - 65,957
Capital Expenditures (CapEx)		 0.00 0.00 300 370 399 337 327 285 278 - 267
Net Nonoperating Expense (NNE)		 287 2,120 -864 307 260 277 310 272 298 - 293
Net Nonoperating Obligations (NNO)		 38,813 64,812 70,958 41,167 75,595 41,266 74,168 40,706 43,386 - 72,997
Total Depreciation and Amortization (D&A)		 766 765 741 738 650 646 674 682 697 - 650
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $4.79 $3.54 ($0.97) $5.51 $2.65 $5.06 $4.88 $5.76 $7.02 $4.67 $6.30
Adjusted Weighted Average Basic Shares Outstanding		 292.62M 292.36M 284.07M 279.55M 278.15M 273.68M 267.14M 266.93M 267.13M 263.53M 264.53M
Adjusted Diluted Earnings per Share		 $4.74 $3.49 ($0.97) $5.45 $2.63 $5.01 $4.85 $5.71 $6.98 $4.64 $6.26
Adjusted Weighted Average Diluted Shares Outstanding		 292.62M 292.36M 284.07M 279.55M 278.15M 273.68M 267.14M 266.93M 267.13M 263.53M 264.53M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 292.62M 292.36M 284.07M 279.55M 278.15M 273.68M 267.14M 266.93M 267.13M 263.53M 264.53M
Normalized Net Operating Profit after Tax (NOPAT)		 1,736 384 281 1,936 1,085 1,813 1,720 1,904 2,271 - 2,154
Normalized NOPAT Margin		 3.54% 0.77% 0.51% 3.20% 1.73% 2.75% 2.62% 2.83% 3.25% - 3.13%
Pre Tax Income Margin		 3.75% 0.38% 0.14% 3.29% 1.90% 3.05% 2.51% 3.01% 3.29% - 3.30%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 25.99% 26.99% 38.48% 38.08% 46.01% 41.48% 29.23% 29.38% 24.41% - 23.98%
Augmented Payout Ratio		 89.28% 69.51% 177.14% 193.63% 211.91% 227.66% 112.95% 115.31% 95.28% - 55.33%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, four-year trend snapshot for Cigna Group (CI) based on quarterly income, balance sheet, and cash flow data. Items are organized to highlight positives first, then neutral observations, then potential negatives.

  • Total revenue trend: Revenue has climbed from about $45.36B in 2022 Q4 to roughly $72.30B in 2025 Q4, representing sustained top-line growth over the period.
  • Operating cash flow improvement in 2025: Net cash from continuing operating activities rose from about $1.92B in Q1 2025 to about $6.15B in Q4 2025, signaling improving cash generation despite quarterly fluctuations.
  • Balance sheet expansion: Total assets increased from around $150.7B in early 2025 to about $157.9B by 2025 Q3, indicating growth in the asset base.
  • Equity base trend: Total equity and noncontrolling interests rose to roughly the low- to mid-$40B range across 2024–2025, reflecting a strengthening capital base.
  • Shareholder returns: Regular cash dividends per share are maintained at about $1.51 per share per quarter (as seen across multiple 2024–2025 periods), suggesting consistent shareholder returns.
  • Non-interest income mix: Premiums earned and capital gains on investments remain a sizable portion of non-interest income, contributing to a stable earnings mix—but the exact quarterly mix can vary and may affect volatility.
  • Net income from continuing operations trend: Net income from continuing operations remains positive across quarters, with quarterly figures generally in the range of $1.0–$1.3B in 2024–2025, though there are fluctuations quarter to quarter.
  • Rising non-interest expenses: Total Non-Interest Expense has moved into the ~$63–70B range in 2024–2025, indicating a higher cost base that compresses margin despite revenue growth.
  • Cash flow pressure in one quarter: Net cash from continuing operating activities dipped into negative territory in 2025 Q2 (about -$4.0B), highlighting quarterly working capital and timing effects.
  • Leverage and liabilities growth: Long-term debt increased to around $30.9B by 2025 Q3, and Total Liabilities reached roughly $115.9B, suggesting higher leverage and a larger liability stack over time.
05/09/26 01:17 AM ETAI Generated. May Contain Errors.

Cigna Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cigna Group's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Cigna Group's net income appears to be on an upward trend, with a most recent value of $6.29 billion in 2025, rising from $1.84 billion in 2016. The previous period was $3.78 billion in 2024. View Cigna Group's forecast to see where analysts expect Cigna Group to go next.

Over the last 9 years, Cigna Group's total revenue changed from $39.84 billion in 2016 to $274.89 billion in 2025, a change of 590.0%.

Cigna Group's total liabilities were at $116.05 billion at the end of 2025, a 1.2% increase from 2024, and a 141.8% increase since 2017.

In the past 8 years, Cigna Group's cash and equivalents has ranged from $2.97 billion in 2017 to $10.18 billion in 2020, and is currently $7.68 billion as of their latest financial filing in 2025.


Related Companies

Financial statements for NYSE:CI last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel